Developmental engineering the kidney: Leveraging principles of morphogenesis for renal regeneration

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 96, Issue 1, 2012, Pages 30-38

  Basu, Joydeep ^a   Ludlow, John W ^a  

^a Tengion Inc   (United States)

Author keywords

Chronic kidney disease; Kidney; Morphogenesis; Organ regeneration; Regenerative medicine; Tissue engineering

Indexed keywords

CHRONIC KIDNEY DISEASE; DISEASE COURSE; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY REGENERATION; KIDNEY TRANSPLANTATION; MOLECULAR GENETICS; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TISSUE ENGINEERING; TISSUE REGENERATION;

ANIMALS; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MODELS, ANIMAL; REGENERATION; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 84859121093     PISSN: 1542975X     EISSN: 15429768     Source Type: Journal    
DOI: 10.1002/bdrc.20224     Document Type: Review

References (45)

1. Basu J, Ludlow JW. 2010. Platform technologies for tubular organ regeneration. Trends Biotechnol. 28: 526-533.
2. Basu J, Ludlow JW. 2011. Tissue engineering of tubular and solid organs: an industry perspective, advances in regenerative medicine. In: Wislet-Gendebien S, editor. In Tech Open Publishers. ISBN: 978-953-307-732-1. Intech Open Access Publishers, Croatia. Available at:.
3. Basu J, Genheimer CW, O'Reilly DD, N., et al. 2010. Distribution and analysis of stem and progenitor cell populations in large mammal and human kidneys. FASEB J 24: LB35.
4. Basu J, Genheimer CW, Guthrie KI, et al. 2011. Expansion of the human adipose derived stromal vascular fraction yields a population of smooth muscle-like cells with markedly distinct phenotypic and functional properties relative to mesenchymal stem cell. Tissue Eng Part C 17: 843-860.
5. Basu J, Genheimer CW, Rivera EA, et al. 2011. Functional evaluation of primary renal cell/biomaterial Neo-Kidney Augment prototypes for renal tissue engineering. Cell Transplant 20: 1771-1790.
6. Boyle SC, Kim M, Valerius MT, et al. 2011. Notch pathway activation can replace the requirement for Wnt4 and Wnt9b in mesenchymal to epithelial transition of nephron stem cells. Development 138: 4245-4254.
7. Camussi G., Deregibus MC, Bruno S, et al. 2010. Exosomes/microvesicles as a mechanism of cell to cell communication. Kidney Int 78: 838-848.
8. Caplan AI. 2009. Why are MSCs therapeutic? New data: new insight. J Pathol 217: 318-324.
9. Chung IM, Enemchukwu NO, Khaja SD, et al. 2008. Bioadhesive hydrogel microenvironments to modulate epithelial morphogenesis. Biomaterials 29: 2637-2645.
10. Dankers PY, Boomker JM, Huizinga-van der Vlag A, et al. 2011. Bioengineering of living renal membranes consisting of hierarchical, bioactive supramolecular meshes and human tubular cells. Biomaterials 32: 723-733.
11. Dudas PL, Argentieri RL, Farrell FX. 2009. BMP-7 fails to attenuate TGF-beta1-induced epithelial-to-mesenchymal transition in human proximal tubule epithelial cells. Nephrol Dial Transplant 24: 1406-1416.
12. Ekaputra AK, Prestwich GD, Cool SM, et al. 2011. The three dimensional vascularization of growth factor releasing hybrid scaffold of poly (E-caprolactone)/collagen fibers and hyaluronic acid hydrogel. Biomaterials 32: 8108-8117.
13. Ganeva V, Unbekandt M, Davies JE. 2011. An improved kidney dissociation and reaggregation culture system results in nephrons arranged organotypically around a single collecting duct. Organogenesis 7: 83-87.
14. Genheimer CW, Ilagan RM, Spencer T, et al. Molecular characterization of the regenerative response induced by intra-renal transplantation of selected renal cells in a rodent model of chronic kidney disease. Cells Tissues Organs 0000(in press).
15. Hammerman MR. 2004. Renal organogenesis from transplanted metanephric primordia. J Am Soc Nephrol 15: 1126-1132.
16. Hills CE, Al-Rasheed N, Willars GB, et al. 2009. C-peptide reverses TGF-beta1-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathy. Am J Physiol Renal Physiol 296: F614-F621.
17. Hopkins C, Li J, Rae F, et al. 2009. Stem cell options for kidney disease. J Pathol 217: 265-281.
18. Joraku A, Stern KA, Atala A, et al. 2009. In vitro generation of three dimensional renal structures. Methods 47: 129-133.
19. Kanwar YS, Wada J, Lin S, et al. 2004. Update of extracellular matrix, its receptors and cell adhesion molecules in mammalian nephrogenesis. Am J Physiol Renal Physiol 286: F202-F215.
20. Kelley R, Werdin ES, Bruce AT, et al. 2010. Tubular cell-enriched subpopulation of primary renal cells improves survival and augments kidney function in rodent model of chronic kidney disease. Am J Physiol Renal Physiol 299: F1026-F1039.
21. Kim D, Dressler GR. 2005. Nephrogenic factors promote differentiation of mouse embryonic stem cells into renal epithelia. J Am Soc Nephrol 16: 3527-3534.
22. Kreidberg JA, Sariola H, Loring JM, et al. 1993. WT-1 is required for early kidney development. Cell 74: 679-691.
23. Kunter U, Rong S, Boor P, et al. 2007. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J Am Soc Nephrol 18: 1754-1764.
24. Laupacis A, Keown P, Pus N, et al. 1996. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 50: 235-242.
25. Lenas P, Moos M, Luyten FP. 2009 Developmental engineering: a new paradigm for the design and manufacturing of cell-based products: Part1 from three dimensional cell growth to biomimetics of in vivo product development. Tissue Eng Part B 15: 381-393.
26. Magee CC, Pascual M. 2004. Update in renal transplantation. Arch Intern Med 164: 1373-1388.
27. Narlis M, Grote D, Gaitan Y, et al. 2007. Pax2 and pax8 regulate branching morphogenesis and nephron differentiation in the developing kidney. J Am Soc Nephrol 18: 1121-1129.
28. Osafune K, Nishinamura R, Komazaki S, et al. 2002. In vitro induction of the pronephric duct in Xenopus explants. Dev Growth Differ 44: 161-167.
29. Ott HC, Mathiesen TS, Goh SK, et al. 2008. Perfusion decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 14: 213-221.
30. Paliege A, Rosenberger C, Bondke A, et al. 2010. Hypoxia-inducible factor-2 alpha expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization. Kidney Int 77: 312-318.
31. Reidy KJ, Rosenblum ND. 2009. Cell and molecular biology of kidney development. Semin Nephrol 29: 321-337.
32. Rogers SA, Lowell JA, Hammerman NA, et al. 1998. Transplantation of developing metanephroi into adult rats. Kidney Int 54: 27-37.
33. Rosines E, Schmidt HJ, Nigam SK. 2007a. The effect of hyaluronic acid size and concentration on branching morphogenesis and tubule differentiation in developing kidney culture systems: potential applications to engineering of renal tissues. Biomaterials 28: 4806-4817.
34. Rosines E, Sampogna RV, Johkura K, et al. 2007b. Staged in vitro reconstitution and implantation of engineered rat kidney tissue. Proc Natl Acad Sci 104: 20938-20943.
35. Rosines E, Johkura K, Zhang X, et al. 2010. Constructing kidney-like tissue from cells based on programs for organ development: toward a method for in vitro tissue engineering of the kidney. Tissue Eng Part A 16: 2441-2455.
36. Ross EA, Williams MJ, Hamazaki T, et al. 2009. Embryonic stem cells proliferate and differentiate when seeded into kidney scaffolds. J Am Soc Nephrol 20: 2338-2347.
37. Sagrinati C, Ronconi E, Lazzeri L, et al. 2008. Stem-cell approaches for kidney repair: choosing the right cells. Trends Mol Med 14: 277-285.
38. Song HK, Kim WY, Lee HW, et al. 2006. Developmental expression of hyaluronan in rat kidney. Paper presented at: American Society of Nephrology National Meeting, San Diego: CA.
39. Talens-Visconti R, Bonora A, Jover R, et al. 2006. Hepatogenic differentiation of huan mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells. World J Gastroenterol 12: 5834-5845.
40. Togel FK, Weiss Y, Yang Z, et al. 2007. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 292: F1626-F1635.
41. Vize PD, Woolf AS, Bard JBL, editors. 2003. The kidney. From normal development to congenital disease. Elsevier Academic Press, California, USA.
42. Wolfe RA, Ashby VB, Milford EL, et al. 1999. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341: 1725-1730.
43. Yokoo T, Ohashi T, Shen JS, et al. 2005. Human mesenchymal stem cells in rodent whole-embryo culture are reprogrammed to contribute to kidney tissues. Proc Natl Acad Sci 102: 3296-3300.
44. Yokoo T, Fukui A, Ohashi T, et al. 2006. Xenobiotic kidney organogenesis from human mesenchymal stem cells using a growing rodent embryo. J Am Soc Nephrol 17: 1026-1034.
45. Zeisberg M, Maeshima Y, Mosterman B, et al. 2002. Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells. Am J Pathol 160: 2001-2008.